Home » AI in Drug Discovery: Speeding Up the Search for New Treatments

AI in Drug Discovery: Speeding Up the Search for New Treatments

By

–

AI in Drug Discovery: Speeding Up the Search for New Treatments

NEW YORK, July 13 — For the families watching a loved one struggle with a rare disease or a condition like pulmonary fibrosis, the long wait for new treatments has often felt like a quiet heartbreak. Traditional drug discovery, the process of bringing a single new medicine from a laboratory idea to a pharmacy shelf, typically takes 10 to 15 years and costs over $1 billion per drug.

That timeline is now being compressed by artificial intelligence, a shift that is beginning to change what is possible for patients who have run out of options. The core problem in drug discovery has always been the search.

Scientists must screen enormous chemical libraries, testing millions of molecules to find one that will bind to a specific disease target. AI accelerates this by scanning virtual libraries of billions of molecules, predicting which ones are most likely to work before a single wet-lab experiment begins. In 2020, Insilico Medicine used AI to identify a novel drug candidate for fibrosis in 46 days.

That same process, using conventional methods, would have taken years. For a patient with idiopathic pulmonary fibrosis, a progressive lung disease with few effective treatments, those 46 days represent a dramatic compression of hope.

Pictures of Disease

Recursion Pharmaceuticals takes a different approach. The company uses AI to analyze cellular images — thousands of pictures of human cells treated with various compounds. The AI learns to recognize patterns that indicate a drug is working, even when the mechanism of action is not fully understood.

This technique has been particularly useful for rare diseases, where traditional drug development is often prohibitively expensive because patient populations are too small to justify the billion-dollar investment. For families navigating a rare diagnosis, this technology offers something that has been in short supply: a reason to believe that a treatment might come within their lifetime.

From Lab Bench to Bedside

The milestone that many in the field have been watching came in 2023, when the first AI-discovered drug — a candidate from Insilico Medicine for idiopathic pulmonary fibrosis — entered Phase II clinical trials. That means it is now being tested in patients, moving beyond the computer screen and into the real world of doctors’ offices and hospital beds. AI is also proving useful for giving existing drugs new jobs.

In 2020, researchers used AI to identify baricitinib, an arthritis drug, as a potential treatment for COVID-19. The drug was later authorized for emergency use, a process that would have taken far longer without computational screening.

What the Numbers Mean

The AI drug discovery market was valued at $1.1 billion in 2022 and is expected to grow to $4.9 billion by 2028. Those figures reflect not just investor enthusiasm, but a recognition that the technology is beginning to deliver on its promises. For patients, this growth translates into more drugs entering the pipeline, more clinical trials, and more chances for a therapy to reach the market.

Still, the field is young. Most AI-discovered drugs are still in early-stage trials.

The real test will come as more candidates move through the rigorous process of human testing, where safety and efficacy are proven — or not. For now, the story is one of acceleration. What used to take a decade can now take weeks.

What used to cost a billion dollars can now be done for a fraction of that. And for the families waiting, that speed is everything. Consult your doctor for medical advice.

Sources

{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “AI in Drug Discovery: Speeding Up the Search for New Treatments”, “description”: “NEW YORK, July 13 — For the families watching a loved one struggle with a rare disease or a condition like pulmonary fibrosis, the long…”, “datePublished”: “2026-07-13T09:30:00+00:00”, “author”: {“@type”: “Person”, “name”: “James Roberto”}, “publisher”: {“@type”: “Organization”, “name”: “InfoPulse Today”, “url”: “https://newsfeed.infopulsetoday.com/”}, “citation”: [{“@type”: “CreativeWork”, “url”: “https://en.wikipedia.org/wiki/Drug_discovery”}]}

More stories by

Most read

AI Tools

Artificial Intelligence

Business

World News